Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Brain tumor evaluation using /sup 82/Rb and positron emission tomography

Journal Article · · J. Nucl. Med.; (United States)
OSTI ID:6816842
Positron emission tomography of the brain with 75-sec rubidium-82 obtained from a portable generator (25-day /sup 82/Sr leads to /sup 82/Rb) was used to evaluate the integrity of the blood-brain barrier (BBB) in patients with brain tumors. Rubidium is normally excluded from the central nervous system by the intact BBB, but when the BBB is disrupted by a tumor. Rb enters and pools in the extravascular spaces of the central nervous system. Since Rb is also rapidly cleared from the blood, a high tissue-to-blood ratio of the /sup 82/Rb tracer is achieved in regions of BBB disruption after intravenous injection. With dynamic positron emission tomographic imaging, the extravasation of the Rb tracer can be evaluated independent of the intravascular Rb concentration, and very small changes in the BBB permeability can be detected. The results of our studies in eight patients show that this technique is a promising method for evaluation of the BBB integrity in brain-tumor patients.
Research Organization:
University of California, Berkeley
OSTI ID:
6816842
Journal Information:
J. Nucl. Med.; (United States), Journal Name: J. Nucl. Med.; (United States) Vol. 23:6; ISSN JNMEA
Country of Publication:
United States
Language:
English

Similar Records

Evaluation of blood--brain barrier permeability changes in rhesus monkeys and man using /sup 82/Rb and positron emission tomography
Journal Article · Mon Nov 30 23:00:00 EST 1981 · J. Comput. Assist. Tomogr.; (United States) · OSTI ID:5367987

Evaluation of blood-brain barrier permeability changes in rhesus monkeys and man using 82Rb and positron emission tomography
Journal Article · Mon Nov 30 23:00:00 EST 1981 · J. Comput. Assist. Tomogr.; (United States) · OSTI ID:5367935

Reduced cerebral glucose metabolism and increased brain capillary permeability following high-dose methotrexate chemotherapy: a positron emission tomographic study
Journal Article · Wed Dec 31 23:00:00 EST 1986 · Ann. Neurol.; (United States) · OSTI ID:6592611